The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. (Q46831098)
Jump to navigation
Jump to search
scientific article published in December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. |
scientific article published in December 2005 |
Statements
The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer (English)
Gabriel N Hortobagyi
S Eva Singletary
Thomas A Buchholz
Amit K Garg
Bharat B Aggarwal
Henry M Kuerer
Lajos Pusztai
Massimo Cristofanilli